Insulin‐like growth factor II messenger RNA‐binding protein‐3 is an independent prognostic factor in uterine leiomyosarcoma
Authors:
- 5 January 2018
- journal article
- research article
- Published by Wiley in Histopathology
- Vol. 72 (5) , 739-748
Abstract
Aims: The aim of this study was to identify the prognostic factors of uterine leiomyosarcoma (ULMS).Methods and results: We reviewed 60 cases of surgically resected ULMSs and investigated conventional clinicopathological factors, together with the expression of insulin‐like growth factor II messenger RNA‐binding protein‐3 (IMP3), hormone receptors and cell cycle regulatory markers by immunohistochemistry. Mediator complex subunit 12 (MED12) mutation analysis was also performed. Univariate analyses revealed that advanced stage (P < 0.0001), older age (P = 0.0244) and IMP3 expression (P = 0.0011) were significant predictors of a poor outcome. Multivariate analysis revealed advanced stage (P < 0.0001) and IMP3 (P = 0.0373) as independent predictors of a poor prognosis. Expressions of cell cycle markers and hormone receptors, and MED12 mutations (12% in ULMSs) were not identified as prognostic markers in this study.Conclusions: IMP3 expression in ULMS could be a marker of a poor prognosis.Keywords
This publication has 34 references indexed in Scilit:
- Uterine Leiomyosarcoma Management, Outcome, and Associated Molecular Biomarkers: A Single Institution’s ExperienceAnnals of Surgical Oncology, 2013
- MED12 Alterations in Both Human Benign and Malignant Uterine Soft Tissue TumorsPLOS ONE, 2012
- 14-3-3 fusion oncogenes in high-grade endometrial stromal sarcomaProceedings of the National Academy of Sciences, 2012
- Uterine leiomyosarcomas: Tumor size, mitotic index, and biomarkers Ki67, and Bcl-2 identify two groups with different prognosisGynecologic Oncology, 2011
- Histopathologic Prognostic Factors in Stage I Leiomyosarcoma of the UterusAmerican Journal of Surgical Pathology, 2011
- Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patientsHistopathology, 2009
- RNA‐binding protein insulin‐like growth factor II mRNA‐binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma†Hepatology, 2008
- The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic studyGynecologic Oncology, 2005
- Uterine Leiomyosarcoma: Analysis of Treatment Failures and SurvivalGynecologic Oncology, 1996
- p53 immunoreactivity and mutation of the p53 gene in smooth muscle tumours of the uterine corpusThe Journal of Pathology, 1995